We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 11.38%
3 Technology 10.34%
4 Industrials 9.82%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
876
Monster Beverage
MNST
$94.3B
$411K 0.01%
18,558
-4,974
-21% -$114K
SCZ icon
877
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$410K 0.01%
8,220
+2,685
+49% +$135K
KERX
878
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$407K 0.01%
69,516
+3,600
+5% +$19.7K
GG
879
DELISTED
Goldcorp Inc
GG
$405K 0.01%
29,737
-7,500
-20% -$104K
VSTO
880
DELISTED
Vista Outdoor Inc.
VSTO
$402K 0.01%
10,900
PNQI icon
881
Invesco NASDAQ Internet ETF
PNQI
$528M
$401K 0.01%
24,275
-12,875
-35% -$220K
RGT
882
Royce Global Value Trust
RGT
$99.2M
$401K 0.01%
+49,888
New +$394K
SAP icon
883
SAP
SAP
$212B
$401K 0.01%
4,631
-517
-10% -$44.4K
ARCC icon
884
Ares Capital
ARCC
$13.5B
$400K 0.01%
24,296
-8,645
-26% -$136K
ALL icon
885
Allstate
ALL
$68B
$398K 0.01%
5,372
+386
+8% +$27.2K
FDUS icon
886
Fidus Investment
FDUS
$749M
$398K 0.01%
25,313
-200
-0.8% -$3.18K
JACK icon
887
Jack in the Box
JACK
$312M
$398K 0.01%
3,567
-1,846
-34% -$189K
VVR icon
888
Invesco Senior Income Trust
VVR
$457M
$398K 0.01%
85,849
-7,961
-8% -$35.3K
BND icon
889
Vanguard Total Bond Market
BND
$157B
$394K 0.01%
4,872
-2,369
-33% -$194K
VGM icon
890
Invesco Trust Investment Grade Municipals
VGM
$548M
$393K 0.01%
30,800
+550
+2% +$7.18K
SPLK
891
DELISTED
Splunk Inc
SPLK
$392K 0.01%
+7,669
New +$442K
FCNCA icon
892
First Citizens BancShares
FCNCA
$24.9B
$391K 0.01%
1,100
+400
+57% +$131K
STEW
893
SRH Total Return Fund
STEW
$1.79B
$391K 0.01%
43,700
+10,064
+30% +$86.1K
SCD
894
LMP Capital and Income Fund
SCD
$355M
$388K 0.01%
29,168
SNCR
895
DELISTED
Synchronoss Technologies
SNCR
$388K 0.01%
1,125
-44
-4% -$16.6K
FVL
896
DELISTED
First TrustValue Line 100 Exchange-Traded
FVL
$387K 0.01%
17,900
+2
+0% +$42
GARS
897
DELISTED
Garrison Capital Inc.
GARS
$387K 0.01%
41,435
+2,603
+7% +$24.7K
HAS icon
898
Hasbro
HAS
$13.3B
$385K 0.01%
4,943
-812
-14% -$67K
IGIB icon
899
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$385K 0.01%
7,126
+700
+11% +$38.3K
HMSY
900
DELISTED
HMS Holdings Corp.
HMSY
$384K 0.01%
21,126
-232
-1% -$4.51K

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.